20/20 Biolabs, INC. (AIDX) — S-1 Filings
All S-1 filings from 20/20 Biolabs, INC.. Browse 2 IPO Filing reports with AI-powered summaries and risk analysis.
S-1 Filings (2)
-
20/20 Biolabs Files S-1 for Public Offering
— Apr 6, 2026 Risk: medium
20/20 Biolabs, Inc. filed an S-1 registration statement on April 6, 2026. This filing indicates the company is preparing to offer its securities to the public. -
20/20 Biolabs Eyes Nasdaq Direct Listing with AI-Powered Cancer Test
— Dec 12, 2025 Risk: high
20/20 Biolabs, Inc. (AIDX) is pursuing a direct listing on Nasdaq, registering 15,130,055 shares for resale by existing stockholders. The company develops and c
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX